Login

Reggie Groves, CEO, REVA Medical Inc 00:00:00

Share On Facebook Share On Twitter

Reva develops bioresorbable coronary scaffolds for the treatment of cardiovascular disease.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Philippines' Energy Transition: A Call for National Collaboration | Eric Francia, CEO, Acen Corp.
00:10:00
Robex Resources: Expanding West Africa Gold Production with Sycamore Acquisition
00:10:00
Seizing Investment Opportunities: Leveraging Value Investing Amid Market Fluctuations | David Herro, CIO , Harris Associates.
00:10:00
Expert Insights on Online Reputation and Business Growth with Josh Green from The Mather Group | Josh Green, CEO,The Mather Group.
00:10:00
Rolv Erik Ryssdal, CEO of Schibsted Norway, discusses industry insights during World Newspaper Week in Vienna, Austria.
00:10:00
The Critical Role of Rare Earth Elements in Modern Technology and Defense
00:10:00
Pressures in the Electricity and Gas Sectors| Marc England, CEO, Genesis Energy Ltd.
00:10:00
A Smart Financial Plan Ep. 7: Dr. Derek Tharp on Personality Traits and Retirement Satisfaction | Daniel Yerger - President of MY Wealth Planners
00:10:00
How RooLife Group Ltd Drives Customer Acquisition and Boosts Online Sales| Bryan Carr, CEO, RooLife Group Ltd.
00:10:00
Lions Talk: Final Test Predictions with Shane Williams & Andy Nicol
00:10:00
PYX Resources CEO Highlights Sustainability Efforts and Premium Zircon Operations | Oliver Hasler, Chairman , PYX Resources Ltd.
00:10:00
Understanding the Dynamics of Financial Regulation in Emerging Markets |Brandon White, Managing Director, Charlesbank Capital Partners.

© 2017 - Neuhu+